EDGAR Filing Documents for 0001564590-15-005105

Form 8-K - Current report:

SEC Accession No. 0001564590-15-005105

Filing Date

2015-06-16

Accepted

2015-06-16 16:10:21

Documents

Period of Report

2015-06-11

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	mstx-8k_20150611.htm	8-K	103925
2	EX-10.1	mstx-ex101_201506116.htm	EX-10.1	128350
3	EX-10.2	mstx-ex102_201506117.htm	EX-10.2	34907
4	EX-10.3	mstx-ex103_201506118.htm	EX-10.3	48145
5	EX-10.4	mstx-ex104_201506119.htm	EX-10.4	51958
6	EX-10.5	mstx-ex105_2015061110.htm	EX-10.5	48661
7	EX-10.6	mstx-ex106_2015061111.htm	EX-10.6	50488
8	EX-10.7	mstx-ex107_2015061112.htm	EX-10.7	35408
	Complete submission text file	0001564590-15-005105.txt		503366

Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130

Business Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 8585520866

Mast Therapeutics, Inc. (Filer) CIK: 0001160308 (see all company filings)